Using contrast-medium administration in multiple sclerosis: we need much more confidence than the chance of seeing a shooting star when looking up at the night sky

Elisabeth S Lindland^{1

2}

Affiliations

¹ Department of Radiology, Sorlandet Hospital, Arendal, Norway. Elisabeth.M.S.Lindland@sshf.no.
² Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Elisabeth.M.S.Lindland@sshf.no.

Editorial

Elisabeth S Lindland. Eur Radiol. 2024 Mar.

. 2024 Mar;34(3):1724-1725.

doi: 10.1007/s00330-023-10272-4. Epub 2023 Oct 2.

Elisabeth S Lindland^{1

2}

¹ Department of Radiology, Sorlandet Hospital, Arendal, Norway. Elisabeth.M.S.Lindland@sshf.no.
² Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Elisabeth.M.S.Lindland@sshf.no.

No abstract available

Comment on

Use of gadolinium-based contrast agents in multiple sclerosis: a review by the ESMRMB-GREC and ESNR Multiple Sclerosis Working Group.
Rovira À, Doniselli FM, Auger C, Haider L, Hodel J, Severino M, Wattjes MP, van der Molen AJ, Jasperse B, Mallio CA, Yousry T, Quattrocchi CC; ESMRMB-GREC Working Group and of the ESNR Multiple Sclerosis Working Group. Rovira À, et al. Eur Radiol. 2024 Mar;34(3):1726-1735. doi: 10.1007/s00330-023-10151-y. Epub 2023 Sep 2. Eur Radiol. 2024. PMID: 37658891 Review.

1. Collaborators GBDMS (2019) Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:269–285. https://doi.org/10.1016/S1474-4422(18)30443-5 - DOI
1. Barkhof F, Scheltens P, Frequin ST et al (1992) Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. AJR Am J Roentgenol 159:1041–1047. https://doi.org/10.2214/ajr.159.5.1414773 - DOI - PubMed
1. Miller DH, Barkhof F, Nauta JJ (1993) Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 116(Pt 5):1077–1094. https://doi.org/10.1093/brain/116.5.1077 - DOI - PubMed
1. McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127. https://doi.org/10.1002/ana.1032 - DOI - PubMed
1. Errante Y, Cirimele V, Mallio CA, Di Lazzaro V, Zobel BB, Quattrocchi CC (2014) Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Invest Radiol 49:685–690. https://doi.org/10.1097/RLI.0000000000000072 - DOI - PubMed